Partha Ray

Title(s)Assistant Adjunct Professor, Surgery
SchoolHealth Sciences
ORCID ORCID Icon0000-0002-7075-5463 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Duke University Senior Research Associate2016Surgery
    Duke University Post doctoral Associate 2013Surgery
    Albert Einstein College of MedicinePhD2008Developmental and Molecular Biology
    Albert Einstein College of MedicineMS2004Developmental and Molecular Biology

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Banerjee S, Yoon H, Yebra M, Tang CM, Gilardi M, Shankara Narayanan JS, White RR, Sicklick JK, Ray P. Anti-KIT DNA Aptamer for Targeted Labeling of Gastrointestinal Stromal Tumor. Mol Cancer Ther. 2020 Mar 03. PMID: 32127469.
      View in: PubMed
    2. Narayanan JSS, Ray P, Hayashi T, Whisenant TC, Vicente D, Carson DA, Miller AM, Schoenberger SP, White RR. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model. Cancer Immunol Res. 2019 Oct; 7(10):1714-1726. PMID: 31409607.
      View in: PubMed
    3. Shankara Narayanan JS, Ray P, Naqvi I, White R. A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation. J Vis Exp. 2018 06 08; (136). PMID: 29939178.
      View in: PubMed
    4. Ray P, White RR. Cell-SELEX Identifies a "Sticky" RNA Aptamer Sequence. J Nucleic Acids. 2017; 2017:4943072. PMID: 28194280.
      View in: PubMed
    5. Mi J, Ray P, Liu J, Kuan CT, Xu J, Hsu D, Sullenger BA, White RR, Clary BM. In Vivo Selection Against Human Colorectal Cancer Xenografts Identifies an Aptamer That Targets RNA Helicase Protein DHX9. Mol Ther Nucleic Acids. 2016 Apr 26; 5:e315. PMID: 27115840.
      View in: PubMed
    6. Ray P, Sullenger BA, White RR. Further characterization of the target of a potential aptamer biomarker for pancreatic cancer: cyclophilin B and its posttranslational modifications. Nucleic Acid Ther. 2013 Dec; 23(6):435-42. PMID: 24152208.
      View in: PubMed
    7. Ray P, Viles KD, Soule EE, Woodruff RS. Application of aptamers for targeted therapeutics. Arch Immunol Ther Exp (Warsz). 2013 Aug; 61(4):255-71. PMID: 23563807.
      View in: PubMed
    8. Ray P, Cheek MA, Sharaf ML, Li N, Ellington AD, Sullenger BA, Shaw BR, White RR. Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells. Nucleic Acid Ther. 2012 Oct; 22(5):295-305. PMID: 23030589.
      View in: PubMed
    9. Ray P, Rialon-Guevara KL, Veras E, Sullenger BA, White RR. Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker. J Clin Invest. 2012 May; 122(5):1734-41. PMID: 22484812.
      View in: PubMed
    10. Ray P, White RR. Aptamers for Targeted Drug Delivery. Pharmaceuticals (Basel). 2010 May 27; 3(6):1761-1778. PMID: 27713328.
      View in: PubMed
    11. Ray P, Basu U, Ray A, Majumdar R, Deng H, Maitra U. The Saccharomyces cerevisiae 60 S ribosome biogenesis factor Tif6p is regulated by Hrr25p-mediated phosphorylation. J Biol Chem. 2008 Apr 11; 283(15):9681-91. PMID: 18256024.
      View in: PubMed
    12. Chaudhuri SP, Sundaram G, Bhattacharya A, Ray P, Ray A, Chatterjee IB, Chattopadhyay D. Activation of S phase checkpoint by cigarette smoke extract in Schizosaccharomyces pombe. Yeast. 2005 Nov; 22(15):1223-38. PMID: 16278931.
      View in: PubMed
    13. Ray P.. Retrotranslocation: Endoplasmic Reticulum’s Junk Disposal Mechanism. Einstein Journal of Biology and Medicine. 2004; 21(1):9-13.